Home/Filings/4/0001415889-25-019334
4//SEC Filing

Levy Richard S 4

Accession 0001415889-25-019334

CIK 0001730430other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:39 PM ET

Size

9.2 KB

Accession

0001415889-25-019334

Insider Transaction Report

Form 4
Period: 2025-07-01
Transactions
  • Award

    Restricted Share Units

    2025-07-01+1,1011,101 total
    Class A Ordinary Shares (1,101 underlying)
  • Exercise/Conversion

    Class A Ordinary Share

    2025-07-01+1,10118,474 total
  • Exercise/Conversion

    Restricted Share Units

    2025-07-011,1010 total
    Class A Ordinary Shares (1,101 underlying)
Footnotes (2)
  • [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
  • [F2]The RSUs vested immediately upon grant on July 1, 2025; there was no expiration date for the RSUs.

Issuer

Kiniksa Pharmaceuticals International, plc

CIK 0001730430

Entity typeother

Related Parties

1
  • filerCIK 0001454983

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:39 PM ET
Size
9.2 KB